Boundless Bio, Inc.
For the period ended Sep 30, 2026. Filed Nov 10, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 10, 2026
BOLD$2.45-0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| Boundless Bio, Inc. | ||
| Date: November 10, 2026 | By: | /s/ Jessica Oien |
|---|---|---|
| Jessica Oien | ||
| President, Chief Legal Officer, and Corporate Secretary | ||
| (Principal Executive Officer) | ||
| Date: November 10, 2026 | By: | /s/ David Hinkle |
| David Hinkle | ||
| Senior Vice President, Finance, Controller and Treasurer | ||
| (Principal Financial and Accounting Officer) | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.